Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2025MedScienOpen Access

Natural Killer Cells Therapy: From in Vitro Amplification to Engineering Modification

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJun Chen

Discussion

Loading...

Member takes

Overview

Review highlights NK cell therapy responses in B-cell lymphoma and challenges in tumor microenvironments.

Key Points

  • NK cell therapy shows a 50%-70% response rate in B-cell lymphoma patients, demonstrating significant efficacy.
  • Cytokine and feeder layer co-culture systems can expand NK cells over 500-fold, enhancing therapeutic potential.
  • Genetic engineering, including CRISPR, improves NK cell cytotoxicity against solid tumors, offering innovative solutions.
  • Challenges such as immunosuppressive microenvironments and NK cell persistence must be addressed for broader application.

Cite This Study

Jun Chen (2025) studied this question.

synapsesocial.com/papers/68af61fdad7bf08b1eae28dfhttps://doi.org/10.61173/j13x9317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Engineering Natural Killer Cells for Cancer Immunotherapy: Advances, Challenges, and Future Perspectives2026
  2. 2Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies2025 · 9 citations
  3. 3Harnessing natural killer cells engineering for cancer immunotherapy2024
  4. 4A new era of natural killer cell immunotherapy in tumor treatment: latest advances and cutting-edge perspectives from basic research to clinical practice2026 · 1 citations
  5. 5Recent advances in tumor immunotherapy based on NK cells2025 · 12 citations